- FoI Number
- 2024-207
- Subject
- Colorectal Cancer
- Date Received
- 10/07/2024
- Request and Response
-
- In the past 3 months, how many patients have been treated for Colorectal Cancer [CRC] with the following regimens?
Regimens
Total CRC Patients
Aflibercept plus chemotherapy
0
Bevacizumab plus fluoropyrimidine-based chemotherapy
<5
Capecitabine
<5
CAPIRI
0
CAPOX
<5
Cetuximab with FOLFIRI
0
Cetuximab with FOLFOX
0
Cetuximab as a single agent
0
Cetuximab with Encorafenib
0
Irinotecan as a single agent
0
FOLFIRI
<5
FOLFOX
0
Fluorouracil (5FU) as a single agent
0
Oxaliplatin as a single agent
0
Nivolumab with Ipilimumab
0
Panitumumab with FOLFIRI
0
Panitumumab with FOLFOX
0
Panitumumab as a single agent
0
Pembrolizumab
<5
Any other systemic anti-cancer therapy
0
Palliative care only
0
Where we have provided <5 answers, this is because NHS Shetland considers that providing more specific information/breakdown carries a high risk of identifying individuals. The combination of specific drug, condition, and treatment time period increases the risk of ‘jigsaw identification’. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.
